Skip to main content


Scientific Name(s): Gynostemma pentaphyllum (Thunb.) Makino.
Common Name(s): Amachazuru (Japan), Dungkulcha (Korea), Five-leaf ginseng, Giao-co-lam tea (Vietnam), Herb of immortality, Immortal grass, Jiaogulan, Miracle grass, Penta tea, Poor man’s ginseng, Southern ginseng, Sweet tea vine, Twisting-vine orchid, Xiancao (China)

Medically reviewed by Last updated on Oct 26, 2022.

Clinical Overview


Limited clinical studies have been conducted to support therapeutic applications. Jiaogulan may have a role in the management of type 2 diabetes, obesity, fatty liver disease, immune response (such as asthma), and cancer. G. pentaphyllum extracts may also have a place in beneficial antioxidant therapy.


Clinical information is lacking. Jiaogulan tea (aqueous extract) 6 g/day, in divided doses twice a day 30 minutes before meals, has been studied in 2 clinical trials in patients with type 2 diabetes; 225 mg twice daily was used for 12 weeks in an antiobesity trial.


Contraindications have not yet been identified.


Information regarding safety and efficacy in pregnancy and lactation is lacking.


None well documented.

Adverse Reactions

Severe nausea and increased bowel movements are possible.


No data available for human toxicity.

Scientific Family

  • Cucurbitaceae (Squash)


G. pentaphyllum (synonym: Vitis pentaphyllum) is a climbing, perennial vine native to China, Japan, and parts of Southeast Asia. The plant is dioecious—having both male and female flowers on separate plants. The leaves commonly grow in groups of 5, and small greenish-white florets are produced. Although a member of the gourd/cucumber family, G. pentaphyllum does not produce the characteristic fruit of this family. The plant grows abundantly and is harvested from the wild; it has been brought under cultivation and tissue culture has been achieved. The plant is now naturalized in the hotter, drier parts of the United States.1, 2, 3, 4


Jiaogulan has been incorporated into traditional Chinese medicine only in the last 20 years, although it has a history of folk use in the Guizhou province. Its properties are said to have been investigated when a Chinese census revealed a large number of elderly people in the province reported using the plant. The plant's potential as a sweetening agent stimulated chemical investigations in Japan. Commercialization and scientific study of the leaves have been promoted by provincial Chinese authorities, and the discovery that several ginseng-like saponins occur in the leaves has prompted aggressive promotion of the plant as a substitute for ginseng. The appearance of jiaogulan in American commerce has been heralded in popular publications.5, 6


Plant constituents primarily include sterols, acetylenic sterols, and triterpenols.7 The phenolic, saponin, and flavonoid composition is known to vary both geographically and by genotype.8 A large number of dammarane (triterpene) saponins, called gypenosides, have been elucidated from the plant leaves. Initial work on the gypenosides was undertaken primarily by 1 group of researchers, but constituents continue to be further described.9, 10, 11, 12, 13, 14 Several of these saponins are identical to those found in ginseng, and the content is comparable with that of ginseng roots. However, wide variation in the amount and nature of gypenosides has made standardization of specific gypenosides problematic. Most current products are standardized on total saponin content. High-performance liquid chromatography and liquid chromatography-mass spectrometry methods have been described to identify chemical constituents.15, 16

Uses and Pharmacology

Although jiaogulan contains ginseng-like saponins, it has not been reported to contain the other types of biologically active compounds, acetylenes, and polysaccharides found in ginseng. Thus, while ginseng pharmacology presents a reasonable starting point for investigation, jiaogulan cannot be considered as pharmacologically identical.


Limited antimicrobial activity has been shown for extracts of G. pentaphyllum.(56) A synergistic antifungal effect against Candida albicans has been demonstrated with gypenosides when combined with fluconazole. Alone, the gypenoside MIC exceeded 128 mcg/mL and the fluconazole MIC was over 64 mcg/mL; however, when combined, these MICs dropped to 32 mcg/mL and 0.25 mcg/mL, respectively.(73)


A G. pentaphyllum leaf ethanol extract, actiponin, was shown in experimental studies to improve the expression of key regulatory factors of fat oxidation and lipogenic transcription factors in a dose-dependent manner. As a follow up to subsequent studies in mouse obesity models that demonstrated reduced body fat mass, a double-blind, randomized, placebo-controlled study was conducted in 80 obese participants with a BMI between 25 and 30 who had no other diagnoses. Compared to placebo, administration of actiponin 225 mg twice daily for 12 weeks led to significant improvements in abdominal fat and anthropometric parameters but not lipid parameters. Respectively, the gender-adjusted results for placebo compared to actiponin were abdominal fat (−2.87 vs −20.90 cm2, P=0.044), body weight (−0.08 vs −1.35 kg, P=0.021), BMI (0 vs −0.49, P=0.029), body fat mass (+0.28 vs −1.25; P<0.0001), percent body fat (+0.37 vs −1.16, P<0.0001), and waist circumference (−1.33 vs −2.49 cm; P=0.029). Actiponin was well tolerated with no adverse events reported.(69)


Antioxidant activity has been described for jiaogulan extracts.(14, 32, 33, 34, 35, 36, 57, 58) Cryoprotective effects on spermatozoa, possibly via antioxidant action, was demonstrated by a jiaogulan extract.(59)


Animal data

An in vitro study of gypenosides in mice with leukemia showed increased survival for the treated mice.(17)

Clinical data

In vitro studies have evaluated the cytotoxicity of whole jiaogulan extracts as well as specific chemical constituents against various human cancer cell lines including brain, liver, oral, tongue, colon, and prostate cancers, and leukemia. Induction of cell cycle arrest and apoptosis has been demonstrated.(8, 10, 12, 18, 19, 20, 21, 22, 23, 24, 25) However, clinical trials are lacking.


Animal data

The hot water extract of G. pentaphyllum was found to activate platelet aggregation; however, the active principle was not elucidated.(26) Gypenosides inhibited platelet aggregation in another study.(27) In rabbits, crude gypenosides decreased heart rate, increased stroke volume, dilated blood vessels, and reduced blood pressure while slightly increasing cardiac output.(28) Purified gypenosides 5 and 10 were found to lower systolic and diastolic blood pressure, decrease coronary, brain, and peripheral blood vessel resistance, raise coronary flow, and lower heart rate in dogs.(29) Crude gypenosides protected against cerebral ischemic damage in a rabbit model.(30) Gypensoides protected the cardiac muscle in rats with diabetic cardiomyopathy as measured by left ventricular diastolic and systolic pressure.(31)

Clinical data

Clinical data regarding the use of jiaogulan for cardiovascular effects is lacking.


Antioxidant activity has been described for extracts of jiaogulan on nervous tissue samples.(14, 32)

Animal data

Extracts of G. pentaphyllum fed to rats appeared to protect hippocampus cells from hypoxia/hypoglycemia injury, suggesting a potential application in stroke or reperfusion injury.(33, 34) Similarly, in rats with chronic cerebral hypoperfusion, gypenosides appeared to exert a protective effect.(35)

In rodent models of Parkinson disease, gypenosides were neuroprotective against oxidative injury.(36, 37) Experimental learning deficits induced in mice were attenuated by Gynostemma aqueous extract and specific gypenosides.(38, 39) Anti-depressant actions related to inhibition of neuroinflammation were demonstrated in a chronic unpredictable mild stress mouse model.(72)

In a spinal cord injury mouse model, gypenoside-17 promoted recovery of motor function via a reduction in neuronal apoptosis and inflammatory cytokines (ie, interleukin [IL]-1beta, tumor necrosis factor-alpha, IL-6).(74)

Clinical data

In 72 healthy Korean volunteers with chronic psychological stress, supplementation with G. pentaphyllum extract for 8 weeks in a double-blind, randomized, controlled manner significantly improved Trait Anxiety Scale scores compared to placebo (P=0.041). However, no significant difference was observed in scores between groups based on 3 other scales.(71)


Animal data

In obese mice, oral administration of G. pentaphyllum saponin extract over 8 weeks resulted in decreased body weight.(40) A protective effect was observed by histology in rats with induced fatty liver disease fed jiaogulan.(41) In mice with type 2 diabetes, high-dose G. pentaphyllum extract preserved insulin production and protected the pancreas (on histology).(42)

Clinical data

A small (N = 24) 12-week clinical trial evaluated the effect of jiaogulan tea 6 g/day in patients with type 2 diabetes. Decreases in fasting blood sugar, HbA1c and insulin resistance were observed. No effect on serum lipids was noted. No adverse effects were noted.(43) A similar study (N = 25) conducted by the same researchers found the tea to be effective as add-on therapy to standard gliclazide treatment.(44) A single-blind study evaluated the effect of 80 mL aqueous G. pentaphyllum extract daily over 6 months in nonalcoholic fatty liver disease, and found improvements in both insulin resistance and fatty liver scores.(45)


Animal data

A protectant effect against induced hepatic fibrosis in rats has been demonstrated.(60, 61)

Clinical data

A single-blind study evaluated the effect of 80 mL aqueous G. pentaphyllum extract daily over 6 months in nonalcoholic fatty liver disease, and found improvements in both insulin resistance and fatty liver scores. No other clinical studies were identified in a Cochrane systematic review on herbal medicines for fatty liver disease conducted 7 years later. (45, 68)


Animal data

Results from animal experiments and in vitro studies are equivocal with some,(11, 40, 46, 47) but not all,(48) suggesting improved lipid profiles. Gypenosides significantly reduce plasma trimethylamine-N-oxide (TMAO) levels in mice.(76)

Clinical data

Similarly, limited clinical studies have produced conflicting data.(43, 45, 49, 50, 69) Further quality trials are warranted. The influence of genetic polymorphisms on the metabolic response to consumption of G. pentaphyllum Makino tea was investigated in a small randomized interventional study in 66 hypercholesterolemic participants. Gene variants in 2 genes linked to dyslipidemia, apolipoprotein E (APOE) and cholesteryl ester transfer protein (CETP), were assessed. Although data from the 48 patients who completed the study revealed no significant interaction between tea consumption and APOE or CETP genotypes, G. pentaphyllum demonstrated beneficial effects on total cholesterol and fasting blood glucose in CETP B2 carriers compared to non-B2 carriers (P=0.045 and P=0.026, respectively) and on FBG in APOE non-E4 genotypes versus those with the E4 allele (P=0.042).(67)

Immune response (adaptogen)

In vitro studies suggest G. pentaphyllum extracts have an inhibitory effect on the interleukin response to allergens.(13)

Animal data

Studies in mice and rats have demonstrated moderation of the anti-inflammatory response by the immune system. Airway hyperresponsiveness was reduced in mice,(51, 52) while thymus and spleen response to electric shock stress was muted in mice pretreated with oral extract for 14 days.(53) A protective effect against the adverse effects of cadmium on T-cell functioning has also been demonstrated in rats.(54)

Clinical data

In an older study, cancer patients given jiaogulan granules after chemotherapy showed improved immune function by several end points.(55) However, clinical data regarding the use of jiaogulan for immune effects is lacking.


Animal data

In a retinitis pigmentosa animal model, administration of gypenosides from G. pentaphyllum reduced photoreceptor cell death compared to untreated controls. The mechanism appeared to be related to antioxidant and anti-inflammatory actions.(70) Whereas in an optic neuritis model, gypenosides prevented structural damage of the optic nerve, which recovered to a normal state, compared to controls.(75)


A dose of 3 to 9 g/day dried G. pentaphyllum leaves is recommended in traditional medicine.69 (Park, 2014)


A 20 mg tablet containing 85% gypenosides 2 to 3 times a day is referred to in some texts as a preventive dose, and 60 mg taken 2 to 3 times a day as a treatment dose.6 However, published studies to justify this dosing are lacking.

Diabetes type 2

A small (N = 24) clinical trial evaluated the effect of jiaogulan tea (aqueous extract) 6 g/day taken in divided doses twice a day 30 minutes before meals.43

Nonalcoholic fatty liver disease

Aqueous G. pentaphyllum extract 80 mL daily over 6 months was used in a clinical study.45


225 mg twice daily for 12 weeks was used in a double-blind, randomized, placebo-controlled study conducted in obese patients.69

Pregnancy / Lactation

Information regarding safety and efficacy in pregnancy and lactation is lacking. Although reports specifically on jiaogulan are lacking, caution is warranted as a few isolated ginsenosides have demonstrated embryotoxicity.


Case reports are lacking. Older studies in animals suggested both pro- and antiaggregation action on platelets.26, 27

Adverse Reactions

Severe nausea and increased bowel movements have been reported;62 however, a clinical trial using jiaogulan tea 6 g/day reported no adverse effects.43


Chronic toxicity of jiaogulan was investigated in Wistar rats over 6 months. Doses from 6 mg to 750 mg/kg/day of the extract of the aerial plant parts were orally administered. No differences from controls were found for hematological indices, biochemistry, or histological studies.63 The median lethal oral dose (LD50) has been reported as 49 g/kg in rats, and intraperitoneal LD50 from 1 to 2 g/kg intraperitoneally in mice.64, 65, 66

Index Terms

  • Vitis pentaphyllum



This information relates to an herbal, vitamin, mineral or other dietary supplement. This product has not been reviewed by the FDA to determine whether it is safe or effective and is not subject to the quality standards and safety information collection standards that are applicable to most prescription drugs. This information should not be used to decide whether or not to take this product. This information does not endorse this product as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about this product. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this product. This information is not specific medical advice and does not replace information you receive from your health care provider. You should talk with your health care provider for complete information about the risks and benefits of using this product.

This product may adversely interact with certain health and medical conditions, other prescription and over-the-counter drugs, foods, or other dietary supplements. This product may be unsafe when used before surgery or other medical procedures. It is important to fully inform your doctor about the herbal, vitamins, mineral or any other supplements you are taking before any kind of surgery or medical procedure. With the exception of certain products that are generally recognized as safe in normal quantities, including use of folic acid and prenatal vitamins during pregnancy, this product has not been sufficiently studied to determine whether it is safe to use during pregnancy or nursing or by persons younger than 2 years of age.

More about jiaogulan

Related treatment guides

1. Zhang ZH, Liu H, Zhao LH, Han XZ. Clonal propagation of Gynostemma pentaphyllum (Thunb.) Makino in test tubes [in Chinese]. Zhongguo Zhong Yao Za Zhi. 1989;14(6):335–336, 382.
2. Liu X, Tang F. Tissue culture and plantlet regeneration of Gynostemma pentaphyllum [in Chinese]. Zhong Yao Cai. 1989;12(6):8–10.
3. Wu M, Jiang R. Pharmacognosy of Gynostemma pentaphyllum and Cayratia japonica [in Chinese]. Zhong Yao Cai. 1987;(4):22–25.
4. Ding S, Zhu Z, Li Y. Pharmacognostical study of Gynostemma (Cucurbitaceae) in China [in Chinese]. Yao Xue Xue Bao. 1994;29(2):79–83.
5. Liu J, Blumert M. Jiaogulan: China's Immortality Herb. Badger, CA: Torchlight Publishing; 1999.
6. Duke JA. Handbook of Medicinal Herbs. 2nd ed. CRC Press; 2002:425-426.
7. Gynostemma pentaphyllum (thunb.) makino (vitis pentaphylla thunb.). In: Azimova S, Glushenkova A, eds. Lipids, Lipophilic Components and Essential Oils from Plant Sources. Springer London; 2012:311-312.
8. Xie Z, Liu W, Huang H, et al. Chemical composition of five commercial Gynostemma pentaphyllum samples and their radical scavenging, antiproliferative, and anti-inflammatory properties [published online ahead of print October 12, 2010]. J Agric Food Chem. 2010.20939605
9. Kim JH, Han YN. Dammarane-type saponins from Gynostemma pentaphyllum. Phytochemistry. 2011;72(11-12):1453-1459.21565370
10. Shi L, Cao JQ, Shi SM, Zhao YQ. Triterpenoid saponins from Gynostemma pentaphyllum. J Asian Nat Prod Res. 2011;13(2):168-177.21279881
11. Nguyen PH, Gauhar R, Hwang SL, et al. New dammarane-type glucosides as potential activators of AMP-activated protein kinase (AMPK) from Gynostemma pentaphyllum. Bioorg Med Chem. 2011;19(21):6254-6260.21978948
12. Li N, Wu CF, Xu XY, Liu ZY, Li X, Zhao YQ. Triterpenes possessing an unprecedented skeleton isolated from hydrolyzate of total saponins from Gynostemma pentaphyllum. Eur J Med Chem. 2012;50:173-178.22342101
13. Hung TM, Thu CV, Cuong TD, et al. Dammarane-type glycosides from Gynostemma pentaphyllum and their effects on IL-4-induced eotaxin expression in human bronchial epithelial cells. J Nat Prod. 2010;73(2):192-196.20104880
14. Hu Y, Ip FC, Fu G, Pang H, Ye W, Ip NY. Dammarane saponins from Gynostemma pentaphyllum. Phytochemistry. 2010;71(10):1149-1157.20483436
15. Kao TH, Huang SC, Inbaraj BS, Chen BH. Determination of flavonoids and saponins in Gynostemma pentaphyllum (thunb.) makino by liquid chromatography-mass spectrometry. Anal Chim Acta. 2008;626(2):200-211.18790122
16. Huang SC, Hung CF, Wu WB, Chen BH. Determination of chlorophylls and their derivatives in Gynostemma pentaphyllum makino by liquid chromatography-mass spectrometry. J Pharm Biomed Anal. 2008;48(1):105-112.18573631
17. Hsu HY, Yang JS, Lu KW, et al. An experimental study on the antileukemia effects of gypenosides in vitro and in vivo. Integr Cancer Ther. 2011;10(1):101-112.20702487
18. Tsai YC, Lin CL, Chen BH. Preparative chromatography of flavonoids and saponins in Gynostemma pentaphyllum and their antiproliferation effect on hepatoma cell. Phytomedicine. 2010;18(1):2-10.21036575
19. Zhu H, Liu Z, Tang L, et al. Reversal of P-gp and MRP1-mediated multidrug resistance by H6, a gypenoside aglycon from Gynostemma pentaphyllum, in vincristine-resistant human oral cancer (KB/VCR) cells. Eur J Pharmacol. 2012;696(1-3):43-53.23051672
20. Schild L, Chen BH, Makarov P, Kattengell K, Heinitz K, Keilhoff G. Selective induction of apoptosis in glioma tumour cells by a Gynostemma pentaphyllum extract. Phytomedicine. 2010;17(8-9):589-597.20106643
21. Lu KW, Chen JC, Lai TY, et al. Gypenosides inhibits migration and invasion of human oral cancer SAS cells through the inhibition of matrix metalloproteinase-2 -9 and urokinase-plasminogen by ERK1/2 and NF-kappa B signaling pathways. Hum Exp Toxicol. 2011;30(5):406-415.20511288
22. Lu HF, Chen YS, Yang JS, et al. Gypenosides induced G0/G1 arrest via inhibition of cyclin E and induction of apoptosis via activation of caspases-3 and -9 in human lung cancer A-549 cells. In Vivo. 2008;22(2):215-221.18468406
23. Lu KW, Tsai ML, Chen JC, et al. Gypenosides inhibited invasion and migration of human tongue cancer SCC4 cells through down-regulation of NFkappaB and matrix metalloproteinase-9. Anticancer Res. 2008;28(2A):1093-1099.18507059
24. Chen JC, Lu KW, Tsai ML, et al. Gypenosides induced G0/G1 arrest via CHk2 and apoptosis through endoplasmic reticulum stress and mitochondria-dependent pathways in human tongue cancer SCC-4 cells. Oral Oncol. 2009;45(3):273-283.18674953
25. Cheng TC, Lu JF, Wang JS, Lin LJ, Kuo HI, Chen BH. Antiproliferation effect and apoptosis mechanism of prostate cancer cell PC-3 by flavonoids and saponins prepared from Gynostemma pentaphyllum. J Agric Food Chem. 2011;59(20):11319-11329.21905716
26. Takagi J, Imada T, Kikuchi T, Saito Y, Inada Y. A new platelet aggregation factor from Gynostemma pentaphyllum Makino. Chem Pharm Bull. 1985;33(12):5568–5571.3833397
27. Wu J, Qiu P, Liu J, Mu Q, Xin D. Effects of gypenosides on platelet aggregation release and cAMP level in rabbits [in Chinese]. Chin J Pharmacol Toxicol. 1990;4(1):54–57.
28. Li Y, Ping Li, Meng F, Zhang G, Wang Z. Effects of total gypenosides on heart function and blood pressure of rabbits [in Chinese]. Acta Acad Med Shandong. 1990;28(3):34–36.
29. Chen L, Qiu S, Li Q, He Y. Comparison between the effects of gypenosides and ginsenosides on cardiac function and hemodynamics in dogs [in Chinese]. Chin J Pharmacol Toxicol. 1990;4(1):17–20.
30. Wang Z, Qiu P. Protective effect of gypenoside on acute incomplete cerebral ischemia in rabbits [in Chinese]. Chin J Pharmacol Toxicol. 1992;6(3):204–206.
31. Ge M, Ma S, Tao L, Guan S. The effect of gypenosides on cardiac function and expression of cytoskeletal genes of myocardium in diabetic cardiomyopathy rats. Am J Chin Med. 2009;37(6):1059-1068.19938216
32. Wang P, Niu L, Guo XD, et al. Gypenosides protects dopaminergic neurons in primary culture against MPP(+)-induced oxidative injury. Brain Res Bull. 2010;83(5):266-271.20615455
33. Schild L, Cotte T, Keilhoff G, Brodemann R. Preconditioning of brain slices against hypoxia induced injury by a Gynostemma pentaphyllum extract—stimulation of anti-oxidative enzyme expression. Phytomedicine. 2012;19(8-9):812-818.22516894
34. Schild L, Roth A, Keilhoff G, Gardemann A, Brodemann R. Protection of hippocampal slices against hypoxia/hypoglycemia injury by a Gynostemma pentaphyllum extract. Phytomedicine. 2009;16(8):734-743.19406629
35. Zhang XS, Bi XL, Wan-Xiao, et al. Protein tyrosine phosphatase 1B inhibitory effect by dammarane-type triterpenes from hydrolyzate of total Gynostemma pentaphyllum saponins. Bioorg Med Chem Lett. 2013;23(1):297-300.23177789
36. Wang P, Niu L, Gao L, et al. Neuroprotective effect of gypenosides against oxidative injury in the substantia nigra of a mouse model of Parkinson's disease. J Int Med Res. 2010;38(3):1084-1092.20819446
37. Choi HS, Park MS, Kim SH, Hwang BY, Lee CK, Lee MK. Neuroprotective effects of herbal ethanol extracts from Gynostemma pentaphyllum in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease. Molecules. 2010;15(4):2814-2824.20428081
38. Xu F, Sun X, Zhou H. Anti-aging actions of Gynostemma pentaphyllum and its compound formula [in Chinese]. Chin Tradit Pat Med. 1989;11(5):29–30.
39. Hong SW, Yang JH, Joh EH, Kim HJ, Kim DH. Gypenoside TN-2 ameliorates scopolamine-induced learning deficit in mice. J Ethnopharmacol. 2011;134(3):1010-1013.21333723
40. Gauhar R, Hwang SL, Jeong SS, et al. Heat-processed Gynostemma pentaphyllum extract improves obesity in ob/ob mice by activating AMP-activated protein kinase. Biotechnol Lett. 2012;34(9):1607-1616.22576281
41. Qin R, Zhang J, Li C, et al. Protective effects of gypenosides against fatty liver disease induced by high fat and cholesterol diet and alcohol in rats. Arch Pharm Res. 2012;35(7):1241-1250.22864747
42. Yeo J, Kang YJ, Jeon SM, et al. Potential hypoglycemic effect of an ethanol extract of Gynostemma pentaphyllum in C57BL/KsJ-db/db mice. J Med Food. 2008;11(4):709-716.19053864
43. Huyen VT, Phan DV, Thang P, Hoa NK, Ostenson CG. Antidiabetic effect of Gynostemma pentaphyllum tea in randomly assigned type 2 diabetic patients. Horm Metab Res. 2010;42(5):353-357.20213586
44. Huyen VT, Phan DV, Thang P, Ky PT, Hoa NK, Ostenson CG. Antidiabetic effects of add-on Gynostemma pentaphyllum extract therapy with sulfonylureas in type 2 diabetic patients. Evid Based Complement Alternat Med. 2012;2012:452313.23125867
45. Chou SC, Chen KW, Hwang JS, et al. The add-on effects of Gynostemma pentaphyllum on nonalcoholic fatty liver disease. Altern Ther Health Med. 2006;12(3):34-39.16708768
46. la Cour B, Mølgaard P, Yi Z. Traditional Chinese medicine in treatment of hyperlipidaemia. J Ethnopharmacol. 1995;46(2):125–129.7650951
47. Geng W, Yang Y, Liang J, Li Y, He Q. Effects of Gynostemma pentaphyllum extract on T-lymphocyte and lipid metabolism in rats [in Chinese]. Guangxi Med J. 1988;10(1):8–9.
48. Dai H, Meng Q, Zhu H. Effects of the total saponin of Gynostemma pentaphyllum on lipoproteins [in Chinese]. Zhong Cao Yao. 1989;20(4):172–173.
49. Hu X, Ye C, Li X, et al. Antilipemic effect Gynostemma pentaphyllum in patients [in Chinese]. Fu Jian Yi Yao Za Zhi. 1988;10(5):4–6.
50. Zhou H, Xie X, Sun M. Treatment of hyperlipidemia with Gynostemma pentaphyllum Jiaogulan. Hunan Med J. 1991;8(5):259–260.
51. Huang WC, Kuo ML, Li ML, Yang RC, Liou CJ, Shen JJ. Gynostemma pentaphyllum decreases allergic reactions in a murine asthmatic model. Am J Chin Med. 2008;36(3):579-592.18543390
52. Liou CJ, Huang WC, Kuo ML, Yang RC, Shen JJ. Long-term oral administration of Gynostemma pentaphyllum extract attenuates airway inflammation and Th2 cell activities in ovalbumin-sensitized mice. Food Chem Toxicol. 2010;48(10):2592-2598.20558230
53. Im SA, Choi HS, Choi SO, et al. Restoration of electric footshock-induced immunosuppression in mice by Gynostemma pentaphyllum components. Molecules. 2012;17(7):7695-7708.22732883
54. Suntararuks S, Yoopan N, Rangkadilok N, Worasuttayangkurn L, Nookabkaew S, Satayavivad J. Immunomodulatory effects of cadmium and Gynostemma pentaphyllum herbal tea on rat splenocyte proliferation. J Agric Food Chem. 2008;56(19):9305-9311.18795782
55. Wang J, Cao B, Ying X, Zhou Z. Immunologic effects of jiaogulan granule in 19 cancer patients [in Chinese]. Zhejiang Zhong Yi Za Zhi. 1989;24(10):449.
56. Srichana D, Taengtip R, Kondo S. Antimicrobial activity of Gynostemma pentaphyllum extracts against fungi producing aflatoxin and fumonisin and bacteria causing diarrheal disease. Southeast Asian J Trop Med Public Health. 2011;42(3):704-710.21706950
57. Muller C, Gardemann A, Keilhoff G, Peter D, Wiswedel I, Schild L. Prevention of free fatty acid-induced lipid accumulation, oxidative stress, and cell death in primary hepatocyte cultures by a Gynostemma pentaphyllum extract. Phytomedicine. 2012;19(5):395-401.22381945
58. Chi A, Tang L, Zhang J, Zhang K. Chemical composition of three polysaccharides from Gynostemma pentaphyllum and their antioxidant activity in skeletal muscle of exercised mice. Int J Sport Nutr Exerc Metab. 2012;22(6):479-485.23212320
59. Hu JH, Li QW, Zhang T, Jiang ZL. Effect of Gynostemma pentaphyllum polysaccharide on boar spermatozoa quality following freezing-thawing. Cryobiology. 2009;59(3):244-249.19422816
60. Chen MH, Wang QF, Chen LG, et al. The inhibitory effect of Gynostemma pentaphyllum on MCP-1 and type I procollagen expression in rat hepatic stellate cells. J Ethnopharmacol. 2009;126(1):42-49.19699789
61. Chen MH, Chen SH, Wang QF, et al. The molecular mechanism of gypenosides-induced G1 growth arrest of rat hepatic stellate cells. J Ethnopharmacol. 2008;117(2):309-317.18372131
62. Chen Z, Su H. Progress in the research on the pharmacology of Gynostemma pentaphyllum [in Chinese]. Zhong Yao Cai. 1989;12(6):42–44.
63. Attawish A, Chivapat S, Phadungpat S, et al. Chronic toxicity of Gynostemma pentaphyllum. Fitoterapia. 2004;75(6):539-551.15351107
64. Chen J, Xu H. Antistress action of Gynostemma pentaphyllum [in Chinese]. Chin Tradit Pat Med. 1989;11(1):31–32.
65. Li R, Zhou L, Liao Z, et al. Chemical and pharmacological studies on Gynostemma pentaphyllum. J New Chin Med. 1988;20(4):51–53.
66. Liu X, Gau J, Huang R. Pharmacological studies on the total saponin of Gynostemma pentaphyllum from Guangxi. Chin Tradit Pat Med. 1989;11(8):27–29.
67. Jeenduang N, Sangkaew B, Chantaracha P, et al. APOE and CETP TaqIB polymorphisms influence metabolic responses to Hibiscus sabdariffa L. and Gynostemma pentaphyllum Makino tea consumption in hypercholesterolemic subjects. Asia Pac J Clin Nutr. 2017;26(2):368-378.28244718
68. Liu ZL, Xie LZ, Zhu J, Li GQ, Grant SJ, Liu JP. Herbal medicines for fatty liver diseases. Cochrane Database Syst Rev. 2013 Aug 24;(8):CD009059.23975682
69. Park SH, Huh TL, Kim SY, et al. Antiobesity effect of Gynostemma pentaphyllum extract (actiponin): a randomized, double-blind, placebo-controlled trial. Obesity (Silver Spring). 2014;22(1):63-71.23804546
70. Alhasani RH, Zhou X, Biswas L, et al. Gypenosides attenuate retinal degeneration in a zebrafish retinitis pigmentosa model. Exp Eye Res. 2020;201:108291. doi:10.1016/j.exer.2020.10829133049273
71. Choi EK, Won YH, Kim SY, et al. Supplementation with extract of Gynostemma pentaphyllum leaves reduces anxiety in healthy subjects with chronic psychological stress: A randomized, double-blind, placebo-controlled clinical trial. Phytomedicine. 2019;52:198-205. doi:10.1016/j.phymed.2018.05.00230599899
72. Dong SQ, Zhang QP, Zhu JX, et al. Gypenosides reverses depressive behavior via inhibiting hippocampal neuroinflammation. Biomed Pharmacother. 2018;106:1153-1160. doi:10.1016/j.biopha.2018.07.04030119182
73. Liu Y, Ren H, Wang D, Zhang M, Sun S, Zhao Y. The synergistic antifungal effects of gypenosides combined with fluconazole against resistant Candida albicans via inhibiting the drug efflux and biofilm formation. Biomed Pharmacother. 2020;130:110580. doi:10.1016/j.biopha.2020.11058032745913
74. Sun T, Duan L, Li J, Guo H, Xiong M. Gypenoside XVII protects against spinal cord injury in mice by regulating the microRNA‑21‑mediated PTEN/AKT/mTOR pathway. Int J Mol Med. 2021;48(2):146. doi:10.3892/ijmm.2021.497934132355
75. Wang F, Dang Y, Wang J, Zhou T, Zhu Y. Gypenosides attenuate lipopolysaccharide-induced optic neuritis in rats. Acta Histochem. 2018;120(4):340-346. doi:10.1016/j.acthis.2018.03.00329559175
76. Zhang Q, Guo X, Xie C, et al. Unraveling the metabolic pathway of choline-TMA-TMAO: Effects of gypenosides and implications for the therapy of TMAO related diseases. Pharmacol Res. 2021;173:105884. doi:10.1016/j.phrs.2021.10588434530121

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.